Pulmonology Lasers Market Outlook:
Pulmonology Lasers Market size was valued at USD 6.50 billion in 2024 and is projected to reach USD 24.80 billion by the end of 2037, rising at a CAGR of 10.80% during the forecast period, 2025 to 2037. In 2025, the industry size of pulmonology lasers is estimated at USD 7.20 billion.
The global pulmonology lasers market is on the rise, largely due to an increasing number of patients suffering from respiratory issues such as chronic obstructive pulmonary disease (COPD) and lung cancer. In contrast, lung cancer was responsible for 1.6 million deaths in 2020. This growing patient base is driving demand for laser treatments, particularly for less invasive options such as bronchoscopic laser therapy. When it comes to the supply chain for these lasers, essential materials like optical fibers and rare-earth elements are mainly sourced from. The U.S. Geological Survey reported that in 2023, China exported 50,000 metric tons of rare-earth compounds, which are vital for manufacturing lasers. In North America and Europe, assembly lines are busy integrating these materials into high-precision laser systems. As noted by the U.S. Bureau of Labor Statistics, the Producer Price Index (PPI) for medical equipment manufacturing saw a 4% increase in 2022. Additionally, the Consumer Price Index (CPI) for medical care services, which includes laser procedures, rose by 3.3% from 2021 to 2022.
The global market for pulmonology lasers and related medical devices is facing supply chain issues. The COVID-19 pandemic, unfortunately, led to import restrictions and a shortage of raw materials, leaving over 85% of major economies struggling with trade vulnerabilities. For example, between 2010 and 2020, the U.S. relied on imports for about 6-11% of its high-end medical devices, including laser components that came from China and India. The National Center for Biotechnology Information highlights that shortages of key raw materials, like sodium bicarbonate, are adding even more strain to supply chains. To foster innovation in medical devices, especially laser systems, investing in research, development, and demonstration (RDD) is absolutely essential.
